Resources

Angela Cheramie was born in 1960 in Galliano, Louisiana, about an hour and half south of New Orleans.  She was adopted at birth and has one sister. Growing up, her dad owned a small hardware […]

From May 30 to June 3, AxoSim is a sponsor and co-host of the inaugural MPS World Summit which we are honored to have in our hometown of New Orleans. We hope that you can join us and would […]

We are proud to announce our published paper: Morphine-sensitive synaptic transmission emerges in embryonic rat microphysiological model of lower afferent nociceptive signaling in Science Advances. The work is a collaboration between the academic lab of […]

Blog written by AxoSim Research Assistant Sabrina Dillon March marks Multiple Sclerosis (MS) Awareness Month. MS is a demyelinating disease concerning the central nervous system (CNS). In 2020, approximately 2.8 million individuals were afflicted with […]

AxoSim is excited to be attending its first in-person conference since the pandemic began! Join our team March 27-31st in San Diego for the Society of Toxicology Annual Meeting and ToxExpo. We are exhibiting at Booth […]

Paper Review by AxoSim Research Scientist Kevin Simpson, PhD Three-dimensional cell cultures, such as spheroids, serve as increasingly important models in fundamental and applied research and continue to be developed for use in drug screening.  […]

Our CEO Lowry Curley sat down with our Director of Special Projects Gina Jackson to reflect on AxoSim’s 2021 year in review and what’s ahead in 2022. Check out his video Q&A and see what’s […]

AxoSim is pleased to welcome Chelsea Richardson as our news Sales Manager. She holds a B.S. in Kinesiology and a minor in Communication from Purdue University. She began her career as a research assistant in […]

AxoSim is excited to announce our CEO Lowry Curley is featured in the Tech Tribune’s Profile of a Founder. The company has also made their list of  best start ups in Louisiana for the past […]

My grandmother was an avid cook, gardener, and Lakers fan. When she was 67, she was diagnosed with Alzheimer’s. The disease progressed slowly, thanks in part to an experimental Alzheimer’s drug study she participated in, […]